Apyx Medical (APYX) Invested Capital (2010 - 2026)

Apyx Medical's Invested Capital history runs 17 years deep, the most recent figure standing at $37.5 million for Q1 2026.

• Quarterly Invested Capital changed 0.0% year-over-year to $37.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.0 million (up 33.33% YoY) and the FY2025 annual result came in at $37.5 million, changed 0.0% from the prior year.
• Invested Capital was $37.5 million for Q1 2026 at Apyx Medical, roughly flat from $37.5 million in the prior quarter.
• Across five years, Invested Capital topped out at $37.5 million in Q4 2023 and bottomed at $110000.0 in Q4 2022.
• A 5-year average of $24.5 million and a median of $37.5 million in 2023 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital slumped 39.89% — and 2023, when it surged 33990.91%.
• Apyx Medical's Invested Capital stood at $110000.0 in 2022, then jumped by 33990.91% to $37.5 million in 2023, then changed by 0.0% to $37.5 million in 2024, then changed by 0.0% to $37.5 million in 2025, then changed by 0.0% to $37.5 million in 2026.
• Business Quant data shows APYX's Invested Capital at $37.5 million in Q1 2026, $37.5 million in Q4 2025, and $37.5 million in Q3 2025.